We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.


We currently have no video available for this pitch.

Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer.  Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.  


  • £520,294
    raised of £500,000 goal
  • Stretch
    13 Jul 2018
  • 21
  • 17.24%
    equity offered
  • £2,400,232
    pre-money valuation
  • 24/10/2017
    incorporated 2 years ago
  • Syndicate Room
  • Medical EIS
View on Syndicate Room businessagent.com may earn a commission from partners

Please sign in or register to businessagent.com to comment on this pitch.

Sign In Register

Other pitches in Medical

  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph